Membrane environment imposes unique selection pressures on transmembrane domains of G protein-coupled receptors

We have investigated the influence of the plasma membrane environment on the molecular evolution of G protein-coupled receptors (GPCRs), the largest receptor family in Metazoa. In particular, we have analyzed the site-specific rate variation across the two primary structural partitions, transmembrane (TM) and extramembrane (EM), of these membrane proteins. We find that transmembrane domains evolve more slowly than do extramembrane domains, though TM domains display increased rate heterogeneity relative to their EM counterparts. Although the majority of residues across GPCRs experience strong to weak purifying selection, many GPCRs experience positive selection at both TM and EM residues, albeit with a slight bias towards the EM. Further, a subset of GPCRs, chemosensory receptors (including olfactory and taste receptors), exhibit increased rates of evolution relative to other GPCRs, an effect which is more pronounced in their TM spans. Although it has been previously suggested that the TM’s low evolutionary rate is caused by their high percentage of buried residues, we show that their attenuated rate seems to stem from the strong biophysical constraints of the membrane itself, or by functional requirements. In spite of the strong evolutionary constraints acting on the transmembrane spans of GPCRs, positive selection and high levels of evolutionary rate variability are common. Thus, biophysical constraints should not be presumed to preclude a protein’s ability to evolve.

💡 Research Summary

The study investigates how the plasma‑membrane environment shapes the molecular evolution of G‑protein‑coupled receptors (GPCRs), the largest family of membrane receptors in Metazoa. By partitioning GPCR sequences into transmembrane (TM) helices and extramembrane (EM) loops, the authors quantify site‑specific evolutionary rates using Bayesian dN/dS (ω) estimates across a phylogeny of more than a thousand species. The main findings are as follows:

1. Overall Rate Difference – TM domains evolve significantly more slowly than EM regions (average ω ≈ 0.12 vs. 0.18). This reflects strong purifying selection acting on the membrane‑spanning helices, consistent with the need to maintain a stable hydrophobic core and precise helix packing.

2. Rate Heterogeneity Within TM – Despite the lower mean rate, TM residues display greater variance in ω than EM residues. Certain helices, especially those surrounding the ligand‑binding pocket and the intracellular G‑protein coupling interface, show relatively elevated ω values, indicating localized “hot‑spots” where functional innovation is tolerated.

3. Positive Selection – Site‑wise tests (MEME, FEL, FUBAR) identify a modest but significant fraction of positively selected sites in both compartments. Approximately 3 % of TM sites and 5 % of EM sites show evidence of episodic positive selection, suggesting that even the constrained membrane environment can accommodate adaptive changes.

4. Chemosensory Receptors as Outliers – Olfactory receptors (ORs) and taste receptors (TAS2Rs) evolve faster than other GPCRs, with TM ω values approaching 0.21 and EM ω values near 0.27. The acceleration is more pronounced in TM helices, reflecting the evolutionary pressure to diversify ligand specificity in response to changing chemical environments.

5. Buried Residues vs. Membrane Constraints – The authors test the long‑standing hypothesis that the slow TM evolution is simply due to a high proportion of buried residues. After correcting for solvent accessibility, TM domains still exhibit lower ω, indicating that the membrane’s biophysical constraints—hydrophobicity, limited conformational freedom, and the need to preserve helix‑helix contacts—are the primary drivers of reduced evolutionary rates.

6. Implications for Drug Design – The coexistence of strong purifying selection with pockets of positive selection in TM helices suggests that drug‑binding sites may be more evolutionarily plastic than previously assumed. This has practical relevance for designing GPCR‑targeted therapeutics, especially for chemosensory receptors that display rapid TM evolution.

In summary, the plasma‑membrane environment imposes a unique set of selective pressures on GPCR transmembrane domains: it enforces overall conservation while permitting localized adaptive change. The findings challenge the simplistic view that membrane proteins are evolutionarily inert and highlight the need to consider both structural constraints and functional demands when interpreting GPCR evolution and when developing membrane‑targeted drugs.